Southern German pharmaceutical production and wholesaling group Gehe AG has reported a 50% increase in sales and profits for 1994, helped by the first-time inclusion in group results of the French wholesale company OCP.
Group sales rose 49.4% to 15.2 billion Deutschemarks ($11.08 billion), while net profits went up 50.4% to 140.2 million marks. Drug wholesale turnover in Germany increased by 8.9% to 4.6 billion marks and offset the downturn triggered by the health reform in the previous year. The total market for drugs in Germany expanded by 6% last year over 1993, but Gehe notes that this was still below the level recorded in 1992.
Gross margins just failed to reach 1993 levels, owing to increased competition in eastern Germany.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze